Clarification of Operating Results and Financial Position Clarification of Operating Results and Financial Position D.T.C.Industries public company Limited and Subsidiary Companies For the period
Clarification of Operating Results and Financial Position Clarification of Operating Results and Financial Position D.T.C. Industries Public Company Limited and Subsidiary Companies For the period
Clarification of Operating Results and Financial Position Clarification of Operating Results and Financial Position D.T.C. Industries public company Limited and Subsidiary Companies For the period
Microsoft Word - 3. Financial Position and Operating Performance of Q'1-2017 Our Ref: CEO 016/2017 15 May 2017 Subject Clarification on First Quarter’s Operating Performance (1/2017) Attn. To The
Microsoft Word - 4. Financial Position and Operating Performance of Q'2-2017.doc Our Ref: CEO 017/2017 11 August 2017 Subject Clarification on Second Quarter’s Operating Performance (2/2017) Attn. To
Microsoft Word - 4. Financial Position and Operating Performance of Q'2-2017.doc Our Ref: CEO 017/2017 11 August 2017 Subject Clarification on Second Quarter’s Operating Performance (2/2017) Attn. To
Microsoft Word - 3. Financial Position and Operating Performance of Q'2-2018 Ref: 10 A Sub To : The com 201 follo Rev 394 63.1 incr Cos mill with inve Prof yea bah incr
Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including
and Drug Administration (CFDA), which took around 2 months, that we have got CFDA in early 2018. Sales by product category Consolidated financial statements For the three months period ended March 31
companies lose that leadership position, increased almost 40 percent between 1965 and 2010. Competition has intensified, driven in large part by technology, rapidly changing consumer preferences, and an